Trial NCT03435640

View at ClinicalTrials.gov 
Org. Study IDs: 17-262-01
Secondary IDs: 2018-004625-84

Last trial update was posted on 2023-03-08

MeSH Interventions

Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Merkel Cell Carcinoma, Renal Cell Squamous Cell Carcinoma of Head and Neck Triple Negative Breast Neoplasms

Other Conditions

Colorectal Cancer Head and Neck Squamous Cell Carcinoma Melanoma Merkel Cell Carcinoma Renal Cell Carcinoma Sarcoma Triple Negative Breast Cancer

Stopping Reasons

Based on the overall results from the Phase 1 part of the study the sponsor decided to end the study. The decision was not due to safety reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID